DMAA — DRUGS MADE IN AMER ACQUTN CO

Ownership history in GLAZER CAPITAL, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which GLAZER CAPITAL, LLC reported a position in DRUGS MADE IN AMER ACQUTN CO (DMAA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.85% (2025 Q1)
Avg. % of fund
0.66%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,816,428 -5,864 -0.3% 0.50% $18.8M $10.37
2025 Q3 REDUCED 1,822,292 -158 -0.0% 0.63% $18.7M $10.27
2025 Q2 REDUCED 1,822,450 -502 -0.0% 0.66% $18.6M $10.20
2025 Q1 INITIATED 1,822,952 — — 0.85% $18.3M $10.02
% of Fund (quarterly)    DMAA price (monthly, adj. close)

Other funds also holding DMAA

As of 2025 Q4 — sorted by position size

HEIGHTS CAPITAL MANAGEMENT, INC 2.42% Westchester Capital Management, LLC 3Y 7Y 0.73% Quarry LP 3Y 0.43% Radcliffe Capital Management, L.P. 3Y 7Y 0.31% Bulldog Investors, LLP 3Y 7Y 0.3% Polar Asset Management Partners Inc. 3Y 7Y 0.21% RIVERNORTH CAPITAL MANAGEMENT, LLC 3Y 7Y 0.2% ARISTEIA CAPITAL, L.L.C. 3Y 7Y 0.2% Governors Lane LP 3Y 7Y 0.15% J. Goldman & Co LP 3Y 7Y 0.14%
← Back to GLAZER CAPITAL, LLC Holdings